Rytelo

imetelstat

Approval

ApplicationNDA 217779
Approval dateJun 6, 2024
Approval year2024
SponsorGeron

FDA-approved use

To treat low- to intermediate-1 risk myelodysplastic syndromes

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Rytelo: